Most trend pieces about medical tourism are copies of copies: the same five predictions and the same unsourced numbers, passed from one listicle to the next. This page is meant to be the version you can check. I have gone through the reporting from Travel Daily Media, the February 2026 market study from Future Market Insights, the Medical Tourism Association’s own magazine, Joint Commission International’s new hospital standards and the Global Wellness Institute’s latest economy data, and kept only what survives contact with a source. Here is what is actually changing in 2026, and what is conference talk.
Nobody agrees how big this market is
Start with the number everyone quotes and nobody can defend. Travel Daily Media put the sector at roughly US$35 billion at the close of 2025, growing 16.8 percent a year, with Asia-Pacific taking 46.43 percent of revenue and Thailand, Singapore, India and Malaysia carrying most of it. Future Market Insights, in a report dated 7 February 2026, values the same industry at US$312.5 billion this year and projects US$1,000.2 billion by 2036 at a 12.3 percent compound rate. That is not a rounding disagreement. It is a nine-fold gap between two serious publications describing the same trade in the same year.
The gap has a boring explanation: nobody agrees on what counts. Count only what foreign patients pay hospitals and you get a small number. Add flights, hotels, companions and recovery stays and it triples. Fold in wellness travel and you reach whatever figure your report needs. My advice is to ignore the levels and trust the direction, because on that every source agrees: double-digit growth, driven by healthcare inflation in the rich world pushing patients toward markets that can do the same operation for a tenth of the price.
The map is spreading beyond the capitals
The more useful story is where patients go once they land. Travel Daily Media reports Türkiye consolidating its position in cardiology, oncology and IVF, while in India the traffic is spilling out of Delhi and Mumbai into Jaipur, Amritsar, Lucknow and Chandigarh, second-tier cities offering the same procedures with shorter queues and lower bills. The report sees the same pattern starting in Thailand and Malaysia. The infrastructure is following the patients: Future Market Insights notes that India extended its e-medical visa to citizens of 171 countries as of August 2025, and that IHH Healthcare plans 2,000 new hospital beds in India by 2028.
Diversification is the trend I would bet on, because it compounds. Every second-tier city that lands an accredited hospital and an airport connection undercuts the capital that trained its surgeons. The first-tier hubs will keep the complex cases. The volume work, the hips and the dental restorations, will keep drifting to wherever the queue is shortest and the hotel is cheapest.
The consultation now happens before the flight
The pandemic’s telehealth reflex has hardened into a workflow. Travel Daily Media describes telemedicine moving past the introductory video call toward virtual hospital models: remote expert opinions and patient monitoring at the front of the journey, so the flight is booked only after the doctors agree there is something worth flying for. The same report expects AI across the administrative spine of the trip, from triage of incoming inquiries and appointment scheduling to laboratory analysis and post-operative follow-up.
I take the teleconsult trend more seriously than the AI one, for a simple reason: the accreditor has already moved. Joint Commission International’s 8th edition hospital standards, mandatory for every accreditation survey since 1 January 2025, added an entire Healthcare Technology chapter covering electronic records, telehealth and cybersecurity. Regulators do not write chapters for experiments. AI triage will matter eventually, but in 2026 much of what is sold under that label is routing software with a new name. The teleconsult is different. It moves patient selection to before the ticket is bought, and bad patient selection is where most medical travel disasters begin.
Payers keep circling, slowly
The perennial promise is that insurers will industrialise this market. The Medical Tourism Association’s magazine has documented the pilots: UnitedHealth plans covering more than 200,000 Americans with access to Bumrungrad International in Bangkok and Apollo Hospitals in India, BlueCross BlueShield of South Carolina building its own network of partner hospitals in Thailand, Türkiye, Singapore and Costa Rica, and Californian plans from Blue Shield and Health Net covering over 20,000 patients in Mexican hospitals. The arithmetic behind all of it has not changed: the magazine cites a hip replacement at US$75,000 in the United States against US$9,000 in India.
Here is the honest reading. Most of those pilots are old, and if payer-funded medical travel were going to take off on its own it would have done so by now. What keeps the trend on this list is the direction of the spread: every year of medical inflation in the West widens the gap that a self-funded employer has to explain to its finance director. I would not watch the insurers’ press releases. I would watch their renewal spreadsheets.
Accreditation grows teeth this year
Quality scrutiny is the quietest trend and the most concrete. JCI published the 8th edition of its hospital standards in July 2024 and made it the basis of every survey from 1 January 2025: roughly 10 to 15 percent fewer standards after consolidation, the new technology chapter above, and a set of environmental sustainability requirements that become fully mandatory on 1 January 2026. Future Market Insights calls the decade’s underlying shift the “formalization of cross-border patient pathways through government visa frameworks and global accreditation standards”, with competition moving from cost arbitrage to quality assurance.
For the traveling patient this is the trend with immediate practical use. The badge in the hospital lobby now says something about whether your records are protected and whether the telehealth follow-up meets a standard, not just whether the operating theatre is clean. In a market where every clinic’s website claims excellence, accreditation remains one of the few claims a patient can independently verify, and in 2026 it is a harder badge to hold.
Wellness and medicine keep merging
The wellness economy is now the gravitational field the whole sector orbits. The Global Wellness Institute’s November 2025 data puts it at a record US$6.8 trillion for 2024, double its 2013 size and up 7.9 percent in a year, with a forecast of US$9.8 trillion by 2029; wellness tourism specifically grew 13.8 percent between 2023 and 2024. On the medical side, Travel Daily Media describes the rise of the healthcation: properties like Chiva-Som in Hua Hin and The Farm at San Benito in the Philippines pairing resort recovery with integrated medicine clinics, hospital affiliations and clinical staff, with longevity programmes the expected next step.
The convergence runs in both directions, and I find the resort-to-clinic direction the more interesting one. A hospital adding a recovery wing is an amenity. A resort hiring physicians and buying diagnostic equipment is entering the medical market with hotel margins and hotel marketing, and the accreditation regime described above does not yet reach most of it. The patient wins when clinical accountability arrives with the equipment. Until then, the sharpest question to ask a longevity retreat is the one you would ask a hospital: who is responsible when something goes wrong?
What This Means
Strip out the numbers nobody agrees on and 2026 resolves into one word: formalization. Visa frameworks built specifically for patients, an accreditation edition with new requirements, telehealth written into hospital standards, insurers running quiet arithmetic instead of loud pilots. The market’s size is unknowable; its direction is not, and the machinery around it is hardening. For a patient, two of these trends are usable today: insist on a teleconsult before you book, and check when the accreditation was issued, not just whether the badge exists. For destinations, the lesson cuts harder. The winners of the next five years will not be the countries with the best beaches or even the lowest prices, but the ones that make the paperwork, the data and the follow-up boring and reliable. Everything else on this list is downstream of that.
